TransCode Therapeutics Inc(NASDAQ:RNAZ) 
TransCode Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for treating metastatic disease. The Company's development pipeline includes TTX-MC138, TTX-siPD-L1 and TTX-RIGA, TTX-siLIN28B, and TCD-miR10b.
Founded: 2016
CEO / Co-Founder: Michael Dudley
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 12.89
H 13.17
L 10.64
C 12.89
V 3,390,976
10EMA 12.89
20EMA 12.89
60EMA 12.89
120EMA 12.89
250EMA 12.89